Mr. Speaker, our approach has been to work with the provinces and the drug companies so that they can share information about drug shortages publicly and on a website. Also, it was encouraging that at this year's health ministers meeting, all ministers agreed to work collaboratively on this issue.
We will continue to monitor whether companies make the information available to doctors and patients, and if they do not, then we will be open to considering passing other legislation. We have made significant investments related to tuberculosis research in Canada.